Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Emergent BioSolutions Inc. | 41,572 | reported | 30 Apr 2025 | tx 82+625,400−268,882 |
| ANI PHARMACEUTICALS INC | 25,000 | reported | 30 Mar 2012 | tx 19+220,985 |
| BRISTOL MYERS SQUIBB CO | 22,932.28 | reported | 31 Mar 2006 | tx 12+11,994.03−6,438 |
| 3M CO | 20,185 | reported | 09 May 2006 | tx 7+2,298 |
| GEORGIA PACIFIC CORP | 16,568.755 | reported | 15 May 2004 | tx 2+4,888 |
| CIGNA CORP | 12,035 | reported | 01 Jun 2006 | tx 8+2,517 |
| HENRY SCHEIN INC | 10,811 | reported | 31 Mar 2016 | tx 60+137,932−155,368 |
| EQUIFAX INC | 9,576 | reported | 30 Jun 2004 | tx 8+12,519−6,329 |
| INHIBITEX, INC. | 7,500 | reported | 01 Feb 2007 | tx 4+80,241 |
| UNITED THERAPEUTICS Corp | 0 | reported | 22 Dec 2025 | tx 201+564,675−652,390 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 Dec 2025 | EXERCISE | UNITED THERAPEUTICS Corp | 2,720 | 229.81 USD | |
| 22 Dec 2025 | SALE | UNITED THERAPEUTICS Corp | 4,863 | 512.34 USD | |
| 22 Dec 2025 | SALE | UNITED THERAPEUTICS Corp | 1,087 | 511.22 USD | |
| 22 Dec 2025 | EXERCISE | UNITED THERAPEUTICS Corp | 3,230 | 183.98 USD | |
| 22 Dec 2025 | EXERCISE | UNITED THERAPEUTICS Corp | 3,230 | 0.00 USD | deriv |
| 22 Dec 2025 | EXERCISE | UNITED THERAPEUTICS Corp | 2,720 | 0.00 USD | deriv |
| 25 Jul 2025 | EXERCISE | UNITED THERAPEUTICS Corp | 590 | 0.00 USD | |
| 24 Jul 2025 | GRANT_AWARD | UNITED THERAPEUTICS Corp | 650 | 0.00 USD | deriv |
| 25 Jul 2025 | EXERCISE | UNITED THERAPEUTICS Corp | 590 | 0.00 USD | deriv |
| 24 Jul 2025 | GRANT_AWARD | UNITED THERAPEUTICS Corp | 1,830 | 0.00 USD | deriv |
| 30 Apr 2025 | GRANT_AWARD | Emergent BioSolutions Inc. | 34,403 | 0.00 USD | |
| 30 Apr 2025 | GRANT_AWARD | Emergent BioSolutions Inc. | 15,824 | 0.00 USD | deriv |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 200 | 371.25 USD | |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 752 | 368.67 USD | |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 1,926 | 370.02 USD | |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 100 | 382.63 USD | |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 620 | 381.41 USD | |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 700 | 380.12 USD | |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 200 | 379.30 USD | |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 500 | 374.46 USD | |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 2,200 | 375.00 USD | |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 2,451 | 374.14 USD | |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 1,501 | 373.12 USD | |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 1,400 | 370.30 USD | |
| 18 Dec 2024 | SALE | UNITED THERAPEUTICS Corp | 2,100 | 369.32 USD |